A Clinical Trial to study the effectiveness of Homoeopathy as an additional mode of treatment in combating Corona Virus infection
- Conditions
- Acute respiratory distress syndrome, (2) ICD-10 Condition: B972||Coronavirus as the cause of diseases classified elsewhere, (3) ICD-10 Condition: R05||Cough, (4) ICD-10 Condition: R060||Dyspnea, (5) ICD-10 Condition: R509||Fever, unspecified, (6) ICD-10 Condition: R068||Other abnormalities of breathing, (7) ICD-10 Condition: J128||Other viral pneumonia,
- Registration Number
- CTRI/2020/04/024905
- Lead Sponsor
- Naiminath Homoeopathic Medical College Hospital and Research Centre
- Brief Summary
Theprimary aim of this study is to assess the effectiveness of Homoeopathy as anancillary mode of treatment to the standard treatment protocol for coronavirus.Throughthis study we will also be able to assess the time of recovery in the casewhere patient is experiencing severe acute respiratory syndrome. This willultimately prove to be effective in tackling infected patients having acuterespiratory syndrome where homoeopathic intervention will prove to bebeneficial for their recovery. It will also help in assessing the time ofrecovery of virulent symptoms. During the study, homoeopathic intervention willbe given to the patients and calculation of relapse rate will be done for thesepatients. People with pre existing medical conditions appear to be morevulnerable to becoming severely ill with the virus. Effective Homoeopathic treatmentfor this section of patients can be a game changer in the standard treatmentprotocol for Corona virus.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 100
- •Patients suffering from COVID-19 along with subjective and objective symptoms.
- •Patients with age groups of 5-70 years.
- •Patients of both genders.
- •Patients who are willing to give informed consent.
- •More than 70 years of age and less than age of 5 years.
- •Pregnant females and lactating females.
- •Subjects considered not suitable for the study by the researchers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome of this trial will be measured in terms of clinically recovered case (Covid-19 negative) or death. 21 days
- Secondary Outcome Measures
Name Time Method Recovery in the case where patient is experiencing severe acute respiratory syndrome 2 hours Decrease in the usage of life supportive equipment like ventilator usage, etc 5 days Improvement in the quality of life including virulent symptoms of the patients 24 hours Decrease in the frequency of the dosage of drugs of modern medicine/ conventional treatment according to the standard treatment protocol. 3 days
Trial Locations
- Locations (1)
F.H. Medical College and Hospital
🇮🇳Firozabad, UTTAR PRADESH, India
F.H. Medical College and Hospital🇮🇳Firozabad, UTTAR PRADESH, IndiaDr Shaurabh KumarPrincipal investigator8193896315deepeshg1@gmail.com